Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment?

Nikolovski, Zoran, Watters, David A. K., Stupart, Douglas and Guest, Glenn D. 2015, Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment?, ANZ journal of surgery, vol. In press, pp. 1-4, doi: 10.1111/ans.13144.

Attached Files
Name Description MIMEType Size Downloads

Title Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment?
Author(s) Nikolovski, Zoran
Watters, David A. K.ORCID iD for Watters, David A. K. orcid.org/0000-0002-5742-8417
Stupart, DouglasORCID iD for Stupart, Douglas orcid.org/0000-0002-5571-1673
Guest, Glenn D.
Journal name ANZ journal of surgery
Volume number In press
Start page 1
End page 4
Total pages 4
Publisher Wiley
Place of publication Weinheim, Germany
Publication date 2015-04-24
ISSN 1445-2197
Keyword(s) colorectal surgery
multidisciplinary meeting
treatment management
Summary BACKGROUND: The aim of this study is to determine whether multidisciplinary team (MDT) meetings alter the length of time to treatment (LOTT) for patients with colorectal cancer. METHODS: We conducted a retrospective audit of all patients with colorectal cancer from the Geelong Hospital (TGH) mandatory colorectal database from 1 January 2006 to 3 February 2011. To be included, patients had to have had elective surgical intervention for primary colorectal adenocarcinoma. A comparison of historical controls was conducted between patients discussed in MDT meetings and those managed prior to the introduction of MDT meetings (3 October 2006) to determine the LOTT in days from definitive diagnosis (colonoscopy) to definitive management (surgery, radiotherapy or chemotherapy). RESULTS: In total, the median LOTT for the historical control and MDT era patient populations were 19.5 and 20 days, respectively. Within the MDT era, we noticed significantly longer times to treatment for patients with rectal cancer who were seen in an MDT meeting prior to definitive management than patients who did not have an intervening MDT meeting (P < 0.001). With a difference of 7.5 days, the clinical significance of these findings remains contentious. However, it is worthwhile recognizing this trend in patients who are exhibiting symptoms due to near obstruction or significant bleeding. The LOTT for colon cancer patients remained unchanged. CONCLUSION: The introduction of MDT meetings to TGH has prolonged the LOTT for patients with rectal cancer. These findings pave the way for further revision of the efficiency of MDT meeting at TGH.
Language eng
DOI 10.1111/ans.13144
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 929999 Health not elsewhere classified
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2015, Wiley
Persistent URL http://hdl.handle.net/10536/DRO/DU:30077534

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 5 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 338 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 15 Oct 2015, 11:24:17 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.